The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Yesim Dargaud

Unité d'Hémostase Clinique

Hôpital Edouard Herriot

France

[email]@univ-lyon1.fr

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Unité d'Hémostase Clinique, Hôpital Edouard Herriot, France. 2003 - 2012
  • Laboratory for Clinical Thrombosis and Haemostasis, Department of Internal Medicine, and Cardiovascular Research Institute Maastricht, Maastricht University, Netherlands. 2010
  • Hôpital Edouard Herriot, Comprehensive Haemophilia Treatment Centre, France. 2007

References

  1. The potential role of synovial thrombomodulin in the pathophysiology of joint bleeds in haemophilia. Dargaud, Y., Simpson, H., Chevalier, Y., Scoazec, J.Y., Hot, A., Guyen, O., Baglin, T., Négrier, C. Haemophilia (2012) [Pubmed]
  2. Monitoring platelet dependent thrombin generation in mice. Dargaud, Y., Spronk, H.M., Leenders, P., Hemker, H.C., Ten Cate, H. Thromb. Res. (2010) [Pubmed]
  3. Standardisation of thrombin generation test--which reference plasma for TGT? An international multicentre study. Dargaud, Y., Luddington, R., Gray, E., Lecompte, T., Siegemund, T., Baglin, T., Hogwood, J., Regnault, V., Siegemund, A., Negrier, C. Thromb. Res. (2010) [Pubmed]
  4. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study. Dargaud, Y., Rugeri, L., Vergnes, M.C., Arnuti, B., Miranda, P., Negrier, C., Bestion, A., Desmurs-Clavel, H., Ninet, J., Gaucherand, P., Rudigoz, R.C., Berland, M., Champion, F., Trzeciak, M.C. Br. J. Haematol. (2009) [Pubmed]
  5. New advances in the therapeutic and laboratory management of patients with haemophilia and inhibitors. Dargaud, Y., Lambert, T., Trossaert, M. Haemophilia (2008) [Pubmed]
  6. Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study. Dargaud, Y., Desmurs-Clavel, H., Marin, S., Bordet, J.C., Poplavsky, J.L., Negrier, C. J. Thromb. Haemost. (2008) [Pubmed]
  7. An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy. Dargaud, Y., de Mazancourt, P., Rugeri, L., Hanss, M., Borg, J.Y., Gaucherand, P., Negrier, C., Trzeciak, C. Blood Coagul. Fibrinolysis (2008) [Pubmed]
  8. Haemophilia therapies. Dargaud, Y., Negrier, C. Expert. Opin. Biol. Ther (2007) [Pubmed]
  9. Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype. Dargaud, Y., Trzeciak, M.C., Bordet, J.C., Ninet, J., Negrier, C. Thromb. Haemost. (2006) [Pubmed]
  10. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Dargaud, Y., Béguin, S., Lienhart, A., Al Dieri, R., Trzeciak, C., Bordet, J.C., Hemker, H.C., Negrier, C. Thromb. Haemost. (2005) [Pubmed]
  11. Management of pregnant women with increased risk of venous thrombosis. Dargaud, Y., Rugeri, L., Ninet, J., Negrier, C., Trzeciak, M.C. Int. J. Gynaecol. Obstet (2005) [Pubmed]
  12. Inherited bleeding disorder due to familial type 2 platelet cyclo-oxygenase deficiency. Dargaud, Y., Bordet, J.C., Trzeciak, M.C., Mazet, M., Dechavanne, M., Negrier, C. Thromb. Res. (2005) [Pubmed]
  13. Multiple arterial thromboses in a patient with primary antiphospholipid syndrome receiving a bromocriptine therapy. Dargaud, Y., Pariset, C., Pinede, L., Rugeri, L., Mohammedi, I., Trzeciak, C., Negrier, C., Ninet, J. Lupus (2004) [Pubmed]
  14. Two novel factor V null mutations associated with activated protein C resistance phenotype/genotype discrepancy. Dargaud, Y., Trzeciak, M.C., Meunier, S., Angei, C., Pellechia, D., Négrier, C., Vinciguerra, C., Dargaud, Y. Br. J. Haematol. (2003) [Pubmed]
 
WikiGenes - Universities